The prevalence of E-cadherin loss in ILCs made it a logical target for genetic manipulation; however, initial mouse models showed that somatic Cre recombinase-mediated loss of E-cadherin in the mammary epithelium is insufficient to induce tumor formation [25,124]. Here, CDH1 is linked to neoplasm.